| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net loss | ||||||||
-12,369 | -17,633 | -10,714 | -8,436 | -8,730 | -6,719 | -4,281 | -3,186 | -2,335 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Stock-based compensation expense | ||||||||
1,331 | 1,348 | 1,219 | 3,279 | 325 | 92 | 78 | 76 | 26 |
Amortization of operating lease right-of-use assets | ||||||||
93 | - | - | - | - | - | - | - | - |
Non-cash interest expense | ||||||||
- | - | - | - | - | 243 | 584 | 533 | 282 |
Change in fair value of derivative liability | ||||||||
- | - | - | - | - | 163 | 335 | 294 | 180 |
Change in fair value of warrant liability | ||||||||
- | - | - | - | - | 104 | 37 | 21 | 6 |
Change in operating lease liability | ||||||||
-87 | - | - | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | ||||||||
2,131 | 3,220 | -1,628 | 3,833 | 497 | 82 | 239 | 352 | 506 |
Accounts payable | ||||||||
-7,199 | 7,078 | -1,789 | 828 | -366 | 469 | 1,703 | 120 | 10 |
Accrued expenses and other current liabilities | ||||||||
1,507 | -15 | 2,047 | -897 | 2,266 | -360 | -237 | 332 | 1,206 |
Net cash used in operating activities | ||||||||
-18,855 | -12,407 | -7,839 | -9,059 | -7,002 | -5,869 | -2,020 | -2,162 | -1,131 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchase of available-for-sale securities | ||||||||
41,711 | - | - | - | - | - | - | - | - |
Net cash used in investing activities | ||||||||
-41,711 | - | - | - | - | - | - | - | - |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from issuance of Series B convertible preferred stock, net of cash issuance costs of $186 | ||||||||
- | - | - | - | 3,131 | - | - | - | - |
Proceeds from secondary public offering, net of cash issuance costs of $702 | ||||||||
134,139 | - | - | - | - | - | - | - | - |
Payment of deferred offering costs | ||||||||
1 | - | - | - | 191 | - | - | - | - |
Proceeds from issuance of convertible promissory notes, net of cash issuance costs of $440 | ||||||||
- | - | - | - | - | 0 | 0 | 0 | 5,560 |
Exercise of stock options for common stock under Equity Incentive Plan | ||||||||
81 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | ||||||||
134,219 | 18,320 | -294 | 35,449 | 2,940 | 21,056 | 28 | 9 | 5,560 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | ||||||||
73,653 | 5,785 | -28,011 | 26,390 | -4,062 | 15,187 | -1,992 | -2,153 | 4,429 |
Issuance of warrants | ||||||||
- | - | - | - | 80 | - | - | - | - |
Derivative liability in connection with issuance of convertible promissory notes | ||||||||
- | - | - | - | - | 0 | 0 | 0 | 1,896 |
Private offering costs in accrued expenses | ||||||||
40 | - | - | - | 872 | - | - | - | - |
Secondary offering costs in accounts payable | ||||||||
12 | - | - | - | 79 | - | - | - | - |
Unrealized gain (loss) on marketable securities | ||||||||
-91 | - | - | - | - | - | - | - | - |
2018 Notes | ||||||||
Issuance of warrants | ||||||||
- | - | - | - | - | - | - | 0 | 74 |